Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters
Abstract
Andes virus, an orthohantavirus endemic to South America, causes severe hantavirus cardiopulmonary syndrome associated with human-to-human transmission. No approved treatments or vaccines against this virus are available. We show that a combined treatment with 2 monoclonal antibodies protected Syrian hamsters when administered at midstage or late-stage disease.
Más información
Título de la Revista: | EMERGING INFECTIOUS DISEASES |
Volumen: | 27 |
Número: | 10 |
Editorial: | CENTERS DISEASE CONTROL PREVENTION |
Fecha de publicación: | 2021 |
Página de inicio: | 2707 |
Página final: | 2710 |
Notas: | Emerg Infect Dis. 2021 Oct;27(10):2707-2710. doi: 10.3201/eid2710.210735. |